Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-12

Clinical Trial Update: Increasing Lung Transplant Availability Using Normothermic Ex Vivo Lung Perfusion (EVLP) at a Dedicated EVLP Facility [NA]

View source ↗

Summary

A completed study evaluating normothermic ex vivo lung perfusion (EVLP) at a dedicated facility to increase lung transplant availability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Lung Bioengineering Inc. | Conditions: Lung Diseases | NA | Status: COMPLETED